Viewing Study NCT07099794


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-03-21 @ 7:59 PM
Study NCT ID: NCT07099794
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-01
First Post: 2025-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module